Pfizer
PFE
PFE
1,858 hedge funds and large institutions have $138B invested in Pfizer in 2014 Q4 according to their latest regulatory filings, with 199 funds opening new positions, 718 increasing their positions, 732 reducing their positions, and 61 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
4% more capital invested
Capital invested by funds: $133B → $138B (+$5.1B)
0.41% more ownership
Funds ownership: 73.01% → 73.41% (+0.41%)
2% less repeat investments, than reductions
Existing positions increased: 718 | Existing positions reduced: 732
Holders
1,858
Holding in Top 10
225
Calls
$1.79B
Puts
$1.61B
Top Buyers
| 1 | +$466M | |
| 2 | +$362M | |
| 3 | +$306M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$229M |
| 5 |
First Eagle Investment Management
New York
|
+$160M |
Top Sellers
| 1 | -$2.19B | |
| 2 | -$392M | |
| 3 | -$319M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
-$294M |
| 5 |
O
OppenheimerFunds
New York
|
-$289M |